Gastrointestinal hormone secretion in women with polycystic ovary syndrome: an observational study
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: Is the secretion of gastrointestinal hormones impaired in patients with polycystic ovary syndrome (PCOS)? SUMMARY ANSWER: Gastrointestinal hormone levels were abnormal in patients with PCOS. WHAT IS KNOWN ALREADY: The hormones glucagon-like peptide-1 (GLP-1) and peptide tyrosine-tyrosine (PYY) are both involved in signaling satiety. Secretion of GLP-1 and PYY in response to nutrients in the small intestine plays an important role in energy metabolism. Most PCOS patients are overweight or obese, which suggests dysregulation of appetite. STUDY DESIGN, SIZE, DURATION: In order to evaluate levels of gastrointestinal hormones in PCOS, a cohort study was undertaken, involving 30 PCOS patients and 29 BMI-matched healthy women recruited from Shanghai Renji Hospital between 1 March 2013 and 30 May 2014. PARTICIPANTS/MATERIALS, SETTING, METHODS: After an overnight fast, all participants underwent an oral glucose tolerance test. Blood was sampled frequently for measurement of blood glucose and plasma insulin, total GLP-1 and PYY concentrations. MAIN RESULTS AND THE ROLE OF CHANCE: Fasting and postprandial insulin levels were significantly higher in patients with PCOS compared with the healthy controls (P < 0.05). Fasting and postprandial GLP-1 (t = 0 and 30 min; mean ± SEM) were also higher in PCOS group (17.5 ± 1.07 pM versus 14.1 ± 1.16 pM, P < 0.05; 29.7 ± 2.39 pM versus 22.8 ± 2.09 pM, P < 0.05). However, there were no differences in plasma PYY between patients with PCOS and healthy controls either fasting or postprandially. PYY levels were lower in obese PCOS patients than in lean PCOS patients (P < 0.05). LIMITATIONS, REASONS FOR CAUTION: The study involved a small number of subjects with PCOS, and examined hormone responses to oral glucose rather than a physiological meal. WIDER IMPLICATIONS OF THE FINDINGS: Deficient secretion of GLP-1 and PYY does not contribute to excessive food intake in the pathophysiology of PCOS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Postprandial cholecystokinin has also been reported to be reduced [37] and fasting or postprandial glucagon-like peptide-1 (GLP-1) increased [38] or decreased [39] in women with PCOS.”
From Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success (2021) · cites this paper as [38]
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
March, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction · doi:10.1093/humrep/dep399 · Cited by 1,799 · cited 2×
“…please email: journals.permissions@oup.com Human Reproduction, Vol.30, No.11 pp. 2639–2644, 2015 Advanced Access publication on September 15, 2015 doi:10.1093/humrep/dev231 at U Q L ibrary on O ctober 18, 2015 http://hum rep.oxfordjournals.org/ D ow nloaded from (ESHRE/ASRM) (March et al., 2010).”
BackgroundInfluentialKnochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,516
Knochenhauer, E. S. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.9.3078 · Cited by 1,127
Kiddy, D. S., Hamilton‐Fairley, D., Bush, A., Short, F., Anyaoku, V., Reed, M. J., & Franks, S. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02909.x · Cited by 921
Stepto, N. K., Cassar, S., Joham, A. E., Hutchison, S. K., Harrison, C. L., Goldstein, R. F., & Teede, H. J. (2013) · Human Reproduction · doi:10.1093/humrep/des463 · Cited by 747 · cited 1×
“Insulin resistance is regarded as a key metabolic disorder in PCOS (Stepto et al., 2013) and is exacerbated by obesity.”
BackgroundNew Interpretation of Oral Glucose Tolerance
Mcintyre, N., Holdsworth, C. D., & Turner, D. S. (1964) · The Lancet · doi:10.1016/s0140-6736(64)90011-x · Cited by 738
PLYMATE, S. R., MATEJ, L. A., JONES, R. E., & FRIEDL, K. E. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-3-460 · Cited by 693 · cited 2×
“Given that insulin inhibits hepatic SHBG production (Plymate et al., 1988), it is not surprising that obese PCOS patients”
BackgroundDUNAIF, A., GRAF, M., MANDELI, J., LAUMAS, V., & DOBRJANSKY, A. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-3-499 · Cited by 586 · cited 1×
“It has been reported that 40–80% of PCOS patients are obese or overweight (Dunaif et al., 1987; Franks, 1989).”
BackgroundAttenuated Peptide YY Release in Obese Subjects Is Associated with Reduced Satiety
le Roux, C. W., Batterham, R. L., Aylwin, S. J. B., Patterson, M., Borg, C. M., Wynne, K. J., Kent, A., Vincent, R. P., Gardiner, J., Ghatei, M. A., et al. (2006) · Endocrinology · doi:10.1210/en.2005-0972 · Cited by 552 · cited 1×
“Plasma PYY levels at both fasting and postprandial state are lower in obese than lean individuals (le Roux et al., 2006), and low serum PYY could predispose subjects to develop overweight or obesity (Roth et al., 2005).”
BackgroundWen, C. P., David Cheng, T. Y., Tsai, S. P., Chan, H. T., Hsu, H. L., Hsu, C. C., & Eriksen, M. P. (2009) · Public Health Nutrition · doi:10.1017/s1368980008002802 · Cited by 543 · cited 2×
“25; Wen et al., 2009) and lean PCOS patients was performed by using repeated measures analysis of variance.”
MethodThe effect of obesity on polycystic ovary syndrome: a systematic review and meta‐analysis
Lim, S. S., Norman, R. J., Davies, M. J., & Moran, L. J. (2013) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01053.x · Cited by 539 · cited 2×
“have lower SHBG levels, which in turn contribute to hyperandrogenism and higher bioavailable androgens (Lim et al., 2013).”
BackgroundPOLYCYSTIC OVARY SYNDROME: A CHANGING PERSPECTIVE
FRANKS, S. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb00457.x · Cited by 526 · cited 1×
“It has been reported that 40–80% of PCOS patients are obese or overweight (Dunaif et al., 1987; Franks, 1989).”
BackgroundHavel, P. J. (2001) · Experimental Biology and Medicine · doi:10.1177/153537020122601102 · Cited by 481 · cited 1×
“Gastrointestinal hormones such as cholecystokinin, glucagon-like peptide-1 (GLP-1) and peptide tyrosine–tyrosine (PYY) play an important role in the regulation of appetite and energy intake (Havel, 2001).”
BackgroundSecretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
Nauck, M. A., Vardarli, I., Deacon, C. F., Holst, J. J., & Meier, J. J. (2011) · Diabetologia · doi:10.1007/s00125-010-1896-4 · Cited by 465
Peptide YY3–36 and Glucagon-Like Peptide-17–36 Inhibit Food Intake Additively
Neary, N. M., Small, C. J., Druce, M. R., Park, A. J., Ellis, S. M., Semjonous, N. M., Dakin, C. L., Filipsson, K., Wang, F., Kent, A. S., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0237 · Cited by 371
Effect of Peptide YY3–36 on Food Intake in Humans
Degen, L., Oesch, S., Casanova, M., Graf, S., Ketterer, S., Drewe, J., & Beglinger, C. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.001 · Cited by 366 · cited 1×
“Fat is the most potent stimulator of PYY, followed by carbohydrate and protein (Degen et al., 2005).”
BackgroundElkind-Hirsch, K., Marrioneaux, O., Bhushan, M., Vernor, D., & Bhushan, R. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0115 · Cited by 276 · cited 2×
“, 2015), and it has recently been suggested that these drugs may also benefit patients with PCOS (Elkind-Hirsch et al., 2008; Jensterle et al., 2015).”
BackgroundPeptide YY Is a Regulator of Energy Homeostasis in Obese Children before and after Weight Loss
Roth, C. L., Enriori, P. J., Harz, K., Woelfle, J., Cowley, M. A., & Reinehr, T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1357 · Cited by 147 · cited 2×
“Plasma PYY levels at both fasting and postprandial state are lower in obese than lean individuals (le Roux et al., 2006), and low serum PYY could predispose subjects to develop overweight or obesity (Roth et al., 2005).”
BackgroundDifference in dietary intake between women with polycystic ovary syndrome and healthy controls
Douglas, C. C., Norris, L. E., Oster, R. A., Darnell, B. E., Azziz, R., & Gower, B. A. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.12.054 · Cited by 147 · cited 3×
“pattern with a high glycemic index (Douglas et al., 2006).”
BackgroundInfluentialLittle, T. J., Doran, S., Meyer, J. H., Smout, A. J. P. M., O'Donovan, D. G., Wu, K.-L., Jones, K. L., Wishart, J., Rayner, C. K., Horowitz, M., et al. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00099.2006 · Cited by 130 · cited 1×
“The release of GLP-1 depends on the length and the region of gut exposed to nutrients (Little et al., 2006; Ma et al., 2013), and may also be influenced by habitual dietary intake.”
BackgroundLindén Hirschberg, A., Naessén, S., Stridsberg, M., Byström, B., & Holte, J. (2004) · Gynecological Endocrinology · doi:10.1080/09513590400002300 · Cited by 123 · cited 1×
“These findings imply that an appetite disorder might be involved in pathophysiology of PCOS (Hirschberg et al., 2004).”
BackgroundJensterle, M., Kocjan, T., Kravos, N. A., Pfeifer, M., & Janez, A. (2015) · Endocrine Research · doi:10.3109/07435800.2014.966385 · Cited by 86 · cited 3×
“, 2015), and it has recently been suggested that these drugs may also benefit patients with PCOS (Elkind-Hirsch et al., 2008; Jensterle et al., 2015).”
BackgroundIncretin levels in polycystic ovary syndrome
Vrbikova, J., Hill, M., Bendlova, B., Grimmichova, T., Dvorakova, K., Vondra, K., & Pacini, G. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0097 · Cited by 81 · cited 4×
“We demonstrated higher plasma GLP-1 concentrations in fasting state and in the early phase after oral glucose in women with PCOS compared with BMImatched controls, as reported in a previous study (Vrbikova et al., 2008).”
BackgroundResultInfluentialThe Severity of Menstrual Dysfunction as a Predictor of Insulin Resistance in PCOS
Brower, M., Brennan, K., Pall, M., & Azziz, R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2815 · Cited by 78
Svendsen, P. F., Nilas, L., Madsbad, S., & Holst, J. J. (2009) · Metabolism · doi:10.1016/j.metabol.2008.11.009 · Cited by 68 · cited 3×
“Some studies have demonstrated that postprandial plasma GLP-1 and PYY were lower (Vrbikova et al., 2008) in women with PCOS (Zwirska-Korczala et al., 2008), whereas others failed to show a difference in GLP-1 levels when compared with healthy controls (Gama et al., 1996; Svendsen et al., 2009).”
BackgroundResultThe satiety hormone peptide YY as a regulator of appetite
Vincent, R. P., & le Roux, C. W. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.048488 · Cited by 65
Blerkom, J. V., & Henry, G. W. (1988) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136783 · Cited by 62
Żwirska-Korczala, K., Sodowski, K., Konturek, S. J., Kuka, D., Kukla, M., Brzozowski, T., Cnota, W., Woźniak-Grygiel, E., Jaworek, J. M., Bułdak, R. J., et al. (2008) · PubMed · Cited by 47
Kauffman, R. P., Baker, T. E., Baker, V., Kauffman, M. M., & Castracane, V. D. (2010) · Gynecological Endocrinology · doi:10.3109/09513590903184084 · Cited by 40
Androgen (dihydrotestosterone)–mediated regulation of food intake and obesity in female mice
Kanaya, N., Vonderfecht, S., & Chen, S. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.04.001 · Cited by 38 · cited 1×
“In both animal models and women with PCOS, there is an increase in food intake (Douglas et al., 2006; Kanaya et al., 2013; Zhang et al., 2015).”
BackgroundMa, J., Checklin, H. L., Wishart, J. M., Stevens, J. E., Jones, K. L., Horowitz, M., Meyer, J. H., & Rayner, C. K. (2013) · Diabetologia · doi:10.1007/s00125-013-2876-2 · Cited by 36 · cited 1×
“The release of GLP-1 depends on the length and the region of gut exposed to nutrients (Little et al., 2006; Ma et al., 2013), and may also be influenced by habitual dietary intake.”
BackgroundSelf-citationTsilchorozidou, T., Batterham, R. L., & Conway, G. S. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03285.x · Cited by 33 · cited 2×
“However, metformin use is associated with increased PYY levels, which parallel an improvement in insulin sensitivity (Tsilchorozidou et al., 2008).”
BackgroundWitchel, S. F., Recabarren, S. E., González, F., Diamanti‐Kandarakis, E., Cheang, K. I., Dulęba, A. J., Legro, R. S., Homburg, R., Pasquali, R., Løbo, R. A., et al. (2012) · Endocrine · doi:10.1007/s12020-012-9701-4 · Cited by 30 · cited 1×
“The etiology is not clear, but PCOS is characterized by hyperandrogenism, anovulation and insulin resistance (IR) (March et al., 2010; Witchel et al., 2012; Brower et al., 2013).”
BackgroundTanaka, K., Saisho, Y., Kawai, T., Tanaka, M., Meguro, S., Irie, J., Imai, T., Shigihara, T., Morimoto, J., Yajima, K., et al. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej14-0602 · Cited by 28 · cited 2×
“GLP-1 receptor agonists have been used to promote weight loss in obese diabetic patients (Tanaka et al., 2015), and it has recently been suggested that these drugs may also benefit patients with PCOS (Elkind-Hirsch et al.”
BackgroundThe Entero-Insular Axis in Polycystic Ovarian Syndrome
Garaa, R., Norris, F., Wright, J., Morgan, L., Hampton, S., Watkins, K., & Marks, V (1996) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/000456329603300303 · Cited by 27 · cited 3×
“Some studies have demonstrated that postprandial plasma GLP-1 and PYY were lower (Vrbikova et al., 2008) in women with PCOS (Zwirska-Korczala et al., 2008), whereas others failed to show a difference in GLP-1 levels when compared with healthy controls (Gama et al., 1996; Svendsen et al., 2009).”
BackgroundResultZhang, J., Liu, Y., Liu, X., Xu, L., Zhou, L., Tang, L., Zhuang, J., Guo, W., & Hu, R. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127094 · Cited by 25 · cited 1×
“In both animal models and women with PCOS, there is an increase in food intake (Douglas et al., 2006; Kanaya et al., 2013; Zhang et al., 2015).”
BackgroundDietary habits in adolescent girls with polycystic ovarian syndrome
Eleftheriadou, M., Stefanidis, K., Lykeridou, A., Iliadis, I., & Michala, L. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.984677 · Cited by 22 · cited 2×
“It has been reported that PCOS patients have a daily surplus energy intake of 3% (Eleftheriadou et al., 2015), and exhibit a dietary ........................................................................................ Table II Characteristics of the obese and lean PCOS patients.”
BackgroundIn-vitro fertilization; the ethics
Dunstan, G. R. (1986) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136341 · Cited by 17
Research works printed but not linked: 1
- Tao, 2012, Early impaired beta-cell function in Chinese women with polycystic ovary syndrome, Int J Clin Exp Pathol, 8, 777
Cited by
Dysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary Syndrome
Liu, R., Zhang, C., Shi, Y., Zhang, F., Li, L., Wang, X., Ling, Y., Fu, H., Dong, W., Shen, J., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00324 · Cited by 367
“The fasting PYY level also had conflicting results from different cohort (Zwirska-Korczala et al., 2008; Lin et al., 2015).”
ResultObesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists
Cena, H., Chiovato, L., & Nappi, R. E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa285 · Cited by 356
“Similar basal and postprandial PYY levels in women with PCOS compared with BMI-matched healthy women have also been frequently reported (67-70).”
ResultHe, F.-F., & Li, Y.-M. (2020) · Journal of Ovarian Research · doi:10.1186/s13048-020-00670-3 · Cited by 289
“found an inverse correlation between PYY and insulin as well as between body mass index(BMI) and testosterone [89].”
BackgroundMicrobiome and PCOS: State-of-Art and Future Aspects
Giampaolino, P., Foreste, V., Di Filippo, C., Gallo, A., Mercorio, A., Serafino, P., Improda, F. P., Verrazzo, P., Zara, G., Buonfantino, C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042048 · Cited by 163
“Abbreviations PCOS polycystic vary syndrome HA hyperandrogenism NIH National Institutes of Health ESHRE/ASRM European Society for Human Reproduction and Embryology/American Society for Reproductive Medicine PCOM polycystic ovarian morphology DOGMA dysbiosis of gut microbiota LPS lipopolysaccharide MeSH medical subject…”
BackgroundInfluentialDeswal, R., Yadav, A., & Dang, A. S. (2018) · Systems Biology in Reproductive Medicine · doi:10.1080/19396368.2017.1410591 · Cited by 159
“Of all the studies, 18 were performed in Europe [Dadachanji et al. 2015; Lauritsen et al. 2014; Schweighofer et al. 2012; Kim et al. 2012; Pangaribuan et al. 2012; Schüring et al. 2012; Houjeghani et al. 2012; Koiou et al. 2011; Tarkun et al. 2004; Liu et al. 2008; Li et al. 2006; Sieminska et al. 2004; Richard 2002;…”
Metadata
- Authors
- Lin, T., Li, S., Xu, H., Zhou, H., Feng, R., Liu, W., Sun, Y., & Ma, J.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Ma, Jing
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-09-15
- Volume
- 30
- Issue
- 11
- Pages
- 2639-2644
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2264016184
- Cited by
- 34
- References
- 40
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 5 · 2018: 1 · 2017: 4 · 2016: 2
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Shanghai Jiaotong University, School of Medicine, Science and Technology (12XJ10015)
- Science and Technology Commission of Shanghai Municipality (14441903502)
- Shanghai Municipal Health Bureau (20124273)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- polycystic ovary syndrome, gastrointestinal hormones, glucagon-like peptide-1, peptide YY, satiety, insulin, obesity, dietary intake, energy metabolism, oral glucose tolerance test
- MeSH terms
- Adult, Dipeptides, Female, Gastrointestinal Hormones, Humans, Insulin, Polycystic Ovary Syndrome, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.